Results 81 to 90 of about 21,523 (174)

Effect of famotidine on the pharmacokinetics of apixaban, an oral direct factor Xa inhibitor

Clinical Pharmacology: Advances and Applications, 2013
Vijay V Upreti,1 Yan Song,1 Jessie Wang,2 Wonkyung Byon,3 Rebecca A Boyd,3 Janice M Pursley,4 Frank LaCreta,1 Charles E Frost1 1Clinical Pharmacology and Pharmacometrics, Discovery Medicine and Clinical Pharmacology, 2Exploratory Development Global ...
Upreti VV, Song Y, Wang J, Byon W, Boyd RA, Pursley JM, LaCreta F, Frost CE   +7 more
doaj  

Comparative effectiveness and safety of oral anticoagulants in patients with atrial fibrillation using antiarrhythmic drugs: An international cohort study

British Journal of Clinical Pharmacology, Volume 92, Issue 4, Page 1177-1185, April 2026.
Aim Our international cohort study assessed the comparative effectiveness and safety of direct oral anticoagulants (DOACs) and vitamin K antagonists (VKAs) among patients with non‐valvular atrial fibrillation (NVAF) using antiarrhythmic drugs. Methods Using the United Kingdom's (UK's) Clinical Practice Research Datalink Aurum and Québec claims data, we
Fabian Maximilian Meinert, Jenny Dimakos, Ying Cui, Kristian B. Filion, Christel Renoux, Antonios Douros   +5 more
wiley   +1 more source

Accidental apixaban intoxication in a 23-month-old child: a case report

BMC Pediatrics, 2020
Background Direct oral anticoagulants, such as apixaban, are increasingly used in everyday practice in order to treat or prevent thromboembolic diseases. To date, there is no available data about apixaban pharmacokinetics in children, and no intoxication
Manon Launay, Yara Nasser, Isabelle Maubert, Anne-Cécile Chaux, Xavier Delavenne   +4 more
doaj   +1 more source

Tratamiento antitrombótico en pacientes con fibrilación auricular tras intervención coronaria percutánea, un equilibrio difícil de conseguir [PDF]

, 2022
The combination of antithrombotic treatment (anticoagulant / antiplatelet) that those who AF patients who have ACS and / or must undergo PCI is unclear.
Arrufat Sánchez, Marta, Corbír Pascual, Miguel, Lafuente Gormaz, Carlos, Tarraga López, Pedro J., Yago Gimenez, Pablo   +4 more
core   +1 more source

The Risk of Colonoscopy‐related Bleeding in Patients With or Without Continued Treatment With an Antithrombotic Agent

DEN Open, Volume 6, Issue 1, April 2026.
ABSTRACT Objectives We prospectively investigated the risk of colonoscopy‐related bleeding in relation to antithrombotic treatment. Methods This prospective, observational, single‐center cohort study (NCT02594813) enrolled consecutive patients who underwent colonoscopy, including the removal of colorectal polyps, regardless of the continuation of ...
Emi Nonaka, Ichitaro Horiuchi, Akira Horiuchi, Satoshi Ukai, Noriko Takahata, Kimihiko Oishi   +5 more
wiley   +1 more source

Revista de Medicina e Investigación (Vol. 2 - Núm. 2) [PDF]

, 2014
El compromiso de una institución que forma personal para la salud como es la Facultad de Medicina de la Universidad Autónoma del Estado de México (UAEMex), es el fomentar en el alumnado la capacidad de mantenerse actualizado en los problemas de ...
Bustamante-Montes, Lilia Patricia, Hinojosa-Juárez, Araceli Consuelo   +1 more
core  

A Delicate Balance

Journal of the American Geriatrics Society, EarlyView.
Ami Schattner
wiley   +1 more source

Kuwait Atrial Fibrillation Management Analysis—Insights From a Tertiary Center in Kuwait

Journal of Arrhythmia, Volume 42, Issue 2, April 2026.
Among patients with non‐valvular AF, rhythm control (RC) was pursued in 28.9%. RC was pursued for younger patients and those followed in electrophysiology clinics (33% vs. 5%, p < 0.001). 11.6% of patients received an underdosed DOAC. RC was underutilized in our study, falling short of international benchmarks and guideline recommendations.
S. AlKharji, S. A. Almoosawy, J. AlBalool, E. Shenouda   +3 more
wiley   +1 more source

Cost–effectiveness and budget impact analysis of switching from apixaban to rivaroxaban treatment among patients with nonvalvular atrial fibrillation in a German healthcare setting

Journal of Comparative Effectiveness Research
Aim: Direct oral anticoagulant (DOAC) switching often occurs in patients with nonvalvular atrial fibrillation (NVAF) formedical and nonmedical reasons. Limited data describe the economic consequences of DOAC switching in patients with NVAF.
Rupesh Subash, Thomas Strakosch, Michelle Zhang, Melissa Hagan, Elke Dworatzek, Agnes Kisser, Vasileios Vasilopoulos, Chloe Salter, Carissa Dickerso, Ewa Stawowczyk   +9 more
doaj   +1 more source

ANÁLISIS RETROSPECTIVO DE LOS EVENTOS HEMORRÁGICOS TRAS EL ALTA POR UN EPISODIO DE INSUFICIENCIA CARDIACA EN PACIENTES ANTIAGREGADOS Y/O ANTICOAGULADOS [PDF]

, 2022
INTRODUCCIÓN La insuficiencia cardiaca (IC) es un síndrome clínico que aumenta con la edad siendo por ello el principal motivo de ingreso hospitalario en mayores de 65 años.
Amores Arriaga, Beatriz, Garcés Horna, Vanesa, Rigmany, Andreea   +2 more
core